1. Histone deacetylase inhibitor (HDACi) upregulates activin A and activates the Smad signaling pathway in melanomas. Issue 1 (April 2018) Authors: Lee, Jeeyong; Ko, Jiwon; Yi, Jae Youn Journal: Journal of dermatological science Issue: Volume 90:Issue 1(2018) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Β-Thujaplicin inhibits basal-like mammary tumor growth by regulating glycogen synthase kinase-3β/β-catenin signaling. Issue 5 (26th April 2019) Authors: Chen, Jing; Ko, Jiwon; Kim, Jin Tae; Cho, Jae Seok; Qiu, Shuai; Kim, Gyoung-Deuck; Auh, Joong-Hyuck; Lee, Hong Jin Journal: Food & function Issue: Volume 10:Issue 5(2019) Page Start: 2691 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Β-Thujaplicin modulates estrogen receptor signaling and inhibits proliferation of human breast cancer cells. Issue 6 (3rd June 2015) Authors: Ko, Jiwon; Bao, Cheng; Park, Hyun-Chang; Kim, Minchae; Choi, Hyung-Kyoon; Kim, Young-Suk; Lee, Hong Jin Journal: Bioscience, biotechnology, and biochemistry Issue: Volume 79:Issue 6(2015) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗